Women’s experiences of risk-stratified breast cancer screening in the MyPeBS trial: a qualitative comparative study across two European countries

Author:

McWilliams Lorna1,Roux Alexandra2,Hawkes Rhiannon1ORCID,Cholerton Rachel1,Delattre Hélène3,Bernoux Agnès4,Forzy Marie-Laure5,Evans D. Gareth6,Balleyguier Corinne7,Keatley Debbie8,Vissac-Sabatier Cécile9,Delaloge Suzette7,de Montgolfier Sandrine2,French David P.1,

Affiliation:

1. Manchester Centre for Health Psychology, University of Manchester, Manchester, UK

2. Inserm, IRD, SESSTIM, ISSPAM, Aix Marseille Univ, Marseille, France

3. Centre Régional Dépistage des Cancers – Ile de France Hauts-de-Seine, Nanterre, France

4. Centre Régional Dépistage des Cancers – Ile de France Essonne, Fontenay Les Briis, France

5. Centre Régional Dépistage des Cancers – Hauts-de-France, Lille, France

6. Division of Evolution, Infection and Genomic Sciences, University of Manchester, Manchester, UK

7. Institute Gustave Roussy, Villejuif, France

8. Independent Cancer Patient’s Voice, London, UK

9. Unicancer, Paris, France

Funder

European Union’s Horizon 2020

Manchester National Institute for Health Research (NIHR) Biomedical Research Centre

Publisher

Informa UK Limited

Reference52 articles.

1. Breast Cancer Risk Assessment and Primary Prevention Advice in Primary Care: A Systematic Review of Provider Attitudes and Routine Behaviours

2. Borrelli C. Cohen S. Duncan A. Given-Wilson R. Jenkins J. Kearins O. Pinder S. Sharma N. Sibbering M. Steel J. Turnbull A. & Wallis M. G. (2016). NHS Breast Screening Programme: Clinical guidance for breast cancer screening assessment. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/567600/Clinical_guidance_for_breast__cancer_screening__assessment_Nov_2016.pdf

3. Public health implications from COGS and potential for risk stratification and screening

4. Benefits and harms of annual, biennial, or triennial breast cancer mammography screening for women at average risk of breast cancer: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC)

5. Breast cancer screening programmes and self‐reported mammography use in European countries

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3